v3.26.1
Other Consolidated Financial Statement Detail (Tables)
 6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Other income (expense), net
Components of other (income) expense, net, are summarized as follows:
For the Three Months Ended June 30,For the Six Months Ended June 30,
(In millions)2026202520262025
Interest income$(25.3)$(32.3)$(63.2)$(56.2)
Interest expense82.3 72.6 149.9 132.6 
(Gains) losses on investments, net(41.6)(5.3)(63.9)30.3 
Litigation related expense(0.4)5.2 4.3 8.2 
Foreign exchange (gains) losses, net6.5 10.4 13.0 6.6 
Other, net(3.0)(1.9)(1.9)(4.4)
Total other (income) expense, net$18.5 $48.7 $38.2 $117.1 
Gain (loss) on investments in equity securities
The following table summarizes our (gains) losses on investments, net that relate to our equity securities held during the following periods:
For the Three Months Ended June 30,For the Six Months Ended June 30,
(In millions)2026202520262025
Net (gains) losses recognized on equity securities$(42.8)$(5.3)$(65.1)$30.3 
Less: Net (gains) losses realized on equity securities— — (3.2)(5.4)
Net unrealized (gains) losses recognized on equity securities$(42.8)$(5.3)$(61.9)$35.7 
Accrued expenses and other
Accrued expense and other consists of the following:
(In millions)As of June 30, 2026As of December 31, 2025
Revenue-related reserves for discounts and allowances$980.2 $1,000.4 
Employee compensation and benefits391.3 375.8 
Collaboration expense198.8 280.0 
Royalties and licensing fees337.8 302.4 
Other718.2 844.0 
Total accrued expense and other$2,626.3 $2,802.6 
For additional information on our acquisition of Apellis, please read Note 2, Acquisitions, to these condensed consolidated financial statements.